Zobrazeno 1 - 10
of 462
pro vyhledávání: '"HFmrEF"'
Autor:
Johan Sundström, Johan Ärnlöv, Stelios Karayiannides, Johan Bodegard, Karolina Ersmark, Stefan Gustafsson, Thomas Cars, Maria K. Svensson, Anna Norhammar
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1377-1388 (2024)
Abstract Aims This study aimed to characterize a contemporary population with subtypes of incident or prevalent heart failure (HF) based on reduced (HFrEF), mildly reduced, or preserved (HFpEF) left ventricular ejection fraction (LVEF) and to assess
Externí odkaz:
https://doaj.org/article/899c8b0a6e57407cb92948c2e9448a93
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1567-1579 (2024)
Abstract Aims We aim to explore the associations between serum tyrosine (Tyr) to threonine (Thr) ratio and chronic heart failure (HF) with reduced or mildly reduced ejection fraction (EF) (HFrEF or HFmrEF). Methods and results The study recruited 418
Externí odkaz:
https://doaj.org/article/7615d65c161648a2b12e95716ce825a5
Autor:
Kathleen Connolly, Richard George, Sami Omar, Elin Matsson, Magnus Åstrand, Magnus Althage, Daniel Pettersen, Esha Mohamed, Kelly Fang, Joao A. C. Lima, Mirjana Kujacic, Helena Ödesjö, Michelle Turton, Petra Johannesson, Anders Gabrielsen, Marcin Ufnal
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background Heart failure mortality remains high despite recent progress in pharmacological treatment. AZD3427 is a selective long‐acting analog of relaxin, a vasodilatory hormone with antifibrotic effects. We assessed the safety, pharmacokinetics,
Externí odkaz:
https://doaj.org/article/c0e3f5861c8c440da59d8312baa97e0d
Autor:
Reinhardt M, Schupp T, Abumayyaleh M, Lau F, Schmitt A, Abel N, Akin M, Rusnak J, Akin I, Behnes M
Publikováno v:
Pragmatic and Observational Research, Vol Volume 15, Pp 31-43 (2024)
Marielen Reinhardt,1,* Tobias Schupp,1,* Mohammad Abumayyaleh,1 Felix Lau,1,2 Alexander Schmitt,1 Noah Abel,1 Muharrem Akin,2 Jonas Rusnak,3 Ibrahim Akin,1 Michael Behnes1 1Department of Cardiology, Angiology, Haemostaseology and Medical Inte
Externí odkaz:
https://doaj.org/article/3c6dabaa913f41caada21e2270f81d61
Autor:
Matteo Pagnesi, Carlo Mario Lombardi, Chiara Tedino, Mauro Chiarito, Davide Stolfo, Luca Baldetti, Marianna Adamo, Filippo Calì, Riccardo Maria Inciardi, Daniela Tomasoni, Ferdinando Loiacono, Marta Maccallini, Alessandro Villaschi, Gaia Gasparini, Marco Montella, Stefano Contessi, Daniele Cocianni, Maria Perotto, Giuseppe Barone, Marco Merlo, Alberto Maria Cappelletti, Gianfranco Sinagra, Daniela Pini, Marco Metra
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 136-146 (2024)
Abstract Aims Patients with heart failure (HF) with reduced ejection fraction (EF) (HFrEF), mildly reduced EF (HFmrEF), and preserved EF (HFpEF) may all progress to advanced HF, but the impact of EF in the advanced setting is not well established. Ou
Externí odkaz:
https://doaj.org/article/d9cacd29f711408ebe14196669c93abd
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 50, Iss , Pp 101329- (2024)
Background: We aimed to assess the impact of adding sodium glucose co-transporters-2 inhibitors (SGLT-2I) on cardiac remodeling in type 2 diabetic patients with heart failure with mildly reduced ejection fraction (HFmrEF) that had been under-represen
Externí odkaz:
https://doaj.org/article/67e0bc0b3c9e415da612cc7045ddac33
Autor:
Na Li, Yunlong Zhu, Fangqun Cheng, Yongliang Chen, Xin Peng, Mingxin Wu, Haobo Huang, Lingling Zhang, Min Liao, Sha Xiao, Hui Zhang, Yuying Zhou, Sihao Chen, Zhican Liu, Liqing Yi, Yiqun Peng, Jie Fan, Jianping Zeng
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 2882-2894 (2023)
Abstract Aims Atrial fibrillation (AF) and heart failure (HF) often co‐exist and are closely intertwined. The impact of AF on the outcome of patients with heart failure with mildly‐reduced ejection fraction (HFmrEF) is not fully clear. This study
Externí odkaz:
https://doaj.org/article/4606327584fb41758e8afc6950074104
Autor:
Zhican Liu, Yunlong Zhu, Lingling Zhang, Mingxin Wu, Haobo Huang, Ke Peng, Wenjiao Zhao, Sihao Chen, Xin Peng, Na Li, Hui Zhang, Yuying Zhou, Yongliang Chen, Sha Xiao, Liqing Yi, Jie Fan, Jianping Zeng
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Worsening of heart failure (HF) symptoms is the leading cause of medical contact and hospitalization of patients with mildly reduced ejection fraction (HFmrEF). The prognostic value of signs and symptoms for patients with HFmrEF i
Externí odkaz:
https://doaj.org/article/79245bc89ba748caa0248e9944cbc38e
Autor:
Monika Beles, Imke Masuy, Sofie Verstreken, Jozef Bartunek, Riet Dierckx, Ward Heggermont, Clara Oeste, Marieke De Boeck, Isabelle Fovel, Michael Maris, Zarha Vermeulen, Marc Vanderheyden
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2269-2280 (2023)
Abstract Aims The Cardiovascular Outcomes Retrospective Data analysIS in Heart Failure (CORDIS‐HF) is a single‐centre retrospective study aimed to (i) clinically characterize a real‐world population with heart failure (HF) with reduced (HFrEF)
Externí odkaz:
https://doaj.org/article/53f916f006bb4a5c8bd0f067d27725ac
Autor:
Marin Viđak, Jelena Kursar, Tomislava Bodrožić Džakić Poljak, Tomislav Letilović, Jasmina Ćatić, Vanja Ivanović Mihajlović, Petra Zebić Mihić, Šime Manola, Ivana Jurin
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 6, p 171 (2024)
Heart failure (HF) with mid-range or mildly reduced ejection fraction (HFmrEF) is a separate clinical entity in the HF spectrum, with a left ventricular ejection fraction ranging from 40 to 49%. While sodium glucose co-transporter 2 inhibitors have b
Externí odkaz:
https://doaj.org/article/b6031fbfbc5048858410b58e90dbe7c7